Amedisys Inc (AMED)

Debt-to-capital ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 1,134,540 1,147,760 1,125,200 1,088,180 1,066,510 1,039,910 1,006,780 1,079,120 1,051,570 1,015,740 985,646 966,758 931,351 905,264 874,272 788,153 809,224 756,205 720,851 679,197
Debt-to-capital ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2024 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $1,134,540K)
= 0.00

Amedisys Inc has consistently maintained a debt-to-capital ratio of 0.00 for the periods spanning from March 31, 2020, to December 31, 2024. This implies that the company has not utilized any debt in relation to its capital structure during this time frame. A debt-to-capital ratio of 0.00 indicates that the company's capital is entirely sourced from equity rather than debt financing. This may suggest a conservative financial approach, as the absence of debt can lower financial risk and interest expenses for the company. However, it is essential to note that while a low debt-to-capital ratio can be positive, it may also indicate limited access to debt-based funding for potential growth or investment opportunities. Overall, the consistent 0.00 debt-to-capital ratio reflects Amedisys Inc's stable financial position and prudent capital structure management throughout the analyzed period.


Peer comparison

Dec 31, 2024